Entelos Collaborates With Novartis On In Silico Drug Trials

Filed in archive Corporate and Industrial News , Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics by ruth on August 23, 2006

Before drugs make it to the commercial production, they are first tested in vitro i.e., under laboratory conditions. And then they go through in vivo, or clinical trials involving animal and ultimately, human models. But in between these two stages, did you know that there is also an optional stage called in silico?

Entelos, Inc. is a US-based life sciences company which creates computer models of human physiology designed to reduce the risk, time, and cost of drug discovery and development. The Company's portfolio of proprietary computer models, known as PhysioLab systems, have helped its pharmaceutical customers validate novel drug targets, select and develop compounds, optimize clinical trials, evaluate in-licensing candidates, and better position existing products in competitive markets.

Entelos just entered into a research agreement with Novartis AG to predict the effect of Novartis' drug candidates on "virtual patients" using Entelos' PhysioLab® platforms.

[Photo: Entelos]

Related Entries:

In Silico Screening of Chinese Herbs Using Random Forest - 25 January 2007
Phorecaster: Forecasting Tool Could Reduce Drug Development ... - 14 February 2007
Purdue-Designed Novel Alzheimer's Drug Goes To Human Clinica... - 30 June 2007
Tuberculosis Drug Candidate SQ109 Granted Orphan Drug Status - 30 October 2007

« Cystatin C As A Prognosti... | Main | Human Embryonic Stem Cell... »

Permalink: Entelos Collaborates With Novartis On In Silico Drug Trials

Tags: bioinformatics drug

Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/34085

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Vote for Entelos Collaborates With Novartis On In Silico Drug Trials:

Currently 6.00/10
1
2
3
4
5
6
7
8
9
10

Rating: 6.00 out of 1 vote(s) cast.

Add your response to Entelos Collaborates With Novartis On In Silico Drug Trials:

Name: *

Email: (will never be shown)*

URL:

(* marked fields are required)

Notify me if more comments appear?

Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).

Remember me

Security Code: *
(Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)

We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Share It

Use the search to look for other interesting posts

Contributors (Last 90 days)

Shawn Hessinger (1)
Gloria Gamat (5)
Ruth Schaffer (14)
Creative Weblogging (3)

This site has 1333 entries and is powered by Creative Weblogging since July 2005.

Our Editors recommend

Disclaimer

Some of the contents of this site are protected Creative Weblogging Inc. 2004-2010.

Check out our Sponsored Blogs!

Business Computer Blog (UK)

Are you interested in writing a blog in our network?

See which positions are currently open.

Testimonials

'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'